Why Altium, Bingo, Bionomics, & IOOF shares zoomed higher today

The Altium Limited (ASX:ALU) share price and the IOOF Holdings Limited (ASX:IFL) share price are two of four zooming notably higher on Tuesday. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to build on yesterday's gain. In afternoon trade the benchmark index is up a further 0.4% to 6,114.9 points.

Four shares that are climbing more than most today are listed below. Here's why they have zoomed higher:

The Altium Limited (ASX: ALU) share price has rocketed 20% to $32.47 following the release of its half year results. Investors appear to have been blown away by another impressive result from the electronic design software company. Altium posted half year revenue of US$78 million, EBITDA of US$28.4 million, profit after tax of $23.4 million, and earnings per share of 18 U.S. cents. This represented revenue growth of 26% and net profit after tax growth of 58% on the prior corresponding period.

The Bingo Industries Ltd (ASX: BIN) share price has bounced back from a heavy decline and is 5% higher at $1.23. The waste management company's shares were sold off on Monday when it downgraded its guidance for the full year. According to a broker note out of Macquarie, it was disappointed with the downgrade but believes the selling has been overdone. It has an outperform rating and $1.50 price target on its shares. This price target is down from $2.75 previously.

The Bionomics Ltd (ASX: BNO) share price has continued its ascent and is up a further 5.5% to 19.5 cents. The biotech company's shares rocketed higher on Monday after management revealed that all was not lost for its BNC210 drug candidate. Further data analysis of its disappointing Phase 2 Post Traumatic Stress Disorder (PTSD) trial has shown the potential for significant patient benefit when the drug exposure is adequate.

The IOOF Holdings Limited (ASX: IFL) share price up almost 12% to $5.92 following the release of its half year results. Despite the impact of the Royal Commission, IOOF achieved a 6% increase in underlying net profit after tax from continuing operations in the first half of FY 2019.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Altium. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »